21 results about "Pediococcus acidilactici" patented technology

The application provides a pediococcus acidilactici M4 for low-moisture fermented feed and an application thereof, and belongs to the field of microbial application and feed technology. The application uses the pediococcus acidilactici M4 to prepare fermented total mixed ration. The bacteria have the characteristics of high osmosis and fast acid production, and can reduce the pH value of the fermentation system in a short time; have strong broad-spectrum bacteriostatic effect on escherichia coli, chicken white dysentery salmonella and staphylococcus aureus; and perfectly adapt to the fermentation of low-moisture total mixed ration. The strain is used as the fermentation strain of low-moisture total mixed ration, can significantly reduce the content of acid detergent fiber and neutral detergent fiber, improve the crude protein level, and then improve the digestibility of the daily ration, increase the content of probiotics such as lactic acid bacteria and yeast in the daily ration, reduce the content of pathogenic bacteria such as escherichia coli in the daily ration, and also can improve the content of volatile fatty acid in the daily ration, improve the quality of the daily ration, and improve the feeding value of the daily ration.

The application discloses a method for extracting pectin from coffee mucilage by using microorganisms, and belongs to the field of microbial fermentation. The method comprises the following steps: inoculating Pediococcus acidilactici and Pichia kluyveri compound bacterial liquid with a compound ratio of 2:1 into coffee fresh beans in a fermentation tank, inoculating the bacterial liquid at a concentration of 7logCFU / mL, fermenting at a temperature of 32 DEG C, and fermenting for 36 hours. After the pectin layer is gradually separated from the coffee beans, the pectin in the mucilage is extracted and used for preparing thickening agents, emulsifying agents and gel agents in food.

This invention discloses *Pediococcus lactis* TC-4, which simultaneously degrades nucleosides, purines, and uric acid, and its applications. *Pediococcus lactis* ( Pediococcus acidilactici This invention relates to *Pediococcus lactis* TC-4, with accession number GDMCC No: 67936. *Pediococcus lactis* TC-4 of this invention can efficiently degrade three nucleosides (guanosine, adenosine, and inosine), three purines (guanine, xanthine, and hypoxanthine), and uric acid in vitro. *Pediococcus lactis* TC-4 of this invention can effectively reduce serum uric acid levels in broiler chickens, alleviating and treating hyperuricemia. Compared with traditional chemical drugs for treating hyperuricemia and / or gout, this invention has no toxic side effects on the ecological environment, no residue risk, and is green and safe. This invention has been confirmed at multiple levels, including genetic and animal studies, to have no potential harm to humans, demonstrating its advantages of safety and high efficiency.

This application belongs to the field of microbial technology, and mainly relates to a strain of *Pediococcus lactis* BPA03 and its applications. *Pediococcus lactis* BPA03 is classified and named *Pediococcus lactis*. Pediococcus acidilactici This *Pediococcus lactis* strain BPA03 was deposited on September 28, 2025, at the China General Microbiological Culture Collection Center (CGMCC), located at No. 3, Courtyard 1, Beichen West Road, Chaoyang District, Beijing, with accession number CGMCC No. 36109. It inhibits skin melanin deposition and improves UV photoaging, suppresses the gene expression levels of immune factors such as IL-1β, IL-6, IL-8, and TNF-α, improves the activities of superoxide dismutase, catalase, and glutathione peroxidase, inhibits vinorelbine-induced neutropenia, and improves the inhibition of immune factor expression induced by vinorelbine, thus exhibiting comprehensive anti-aging effects.

This invention provides *Pediococcus lactis* SHI03 and its application in alleviating insulin resistance and type 2 diabetes, belonging to the field of microbial technology. This invention provides *Pediococcus lactis* SHI03, with accession number CCTCC No: M 20242686, and confirms that this strain possesses in vitro α-glucosidase inhibitory activity, exhibiting excellent probiotic and hypoglycemic effects. This invention further provides microbial products containing *Pediococcus lactis* SHI03, including *Pediococcus lactis* SHI03 fermentation broth, *Pediococcus lactis* SHI03 fermentation supernatant, and *Pediococcus lactis* SHI03 cells, and their applications in alleviating high-fat diet-induced insulin resistance and reducing fasting blood glucose in type 2 diabetic mice.

The application belongs to the technical field of microbial application, and relates to a chiral L-lactic acid production engineering bacterium capable of selectively degrading racemic D-lactic acid and application of the chiral L-lactic acid production engineering bacterium. Pediococcus acidilactici The strain is classified and named as Pediococcus acidilactici LJ2071 and is preserved in the China Center for Type Culture Collection, has a preservation number of CCTCC M 20251230 and a preservation date of May 30, 2025. The strain has the ability to efficiently metabolize various types of biomass-derived monosaccharides and synthesize high-concentration and high-chirality L-lactic acid, has a certain degradation capacity for D-lactic acid contained in the fermentation raw material itself, and can use raw material containing a certain amount of racemic lactic acid to produce high-chirality L-lactic acid. When the concentration of racemic D-lactic acid in the fermentation liquor is not more than 1.5 g / L, the chirality of the L-lactic acid product is greater than 99.5%, and the L-lactic acid product can be used as a poly-lactic acid material polymerization monomer.

This invention discloses a PSR primer, kit, and detection method for identifying Pediococcus lactis based on a specific gene target. Based on the conserved sequence of the target gene, this invention designs and optimizes PSR-specific primers, establishes a PSR amplification system, and further provides a kit containing the primers and its application method. The PSR detection method established by this invention features high sensitivity, strong specificity, rapid reaction, simple operation, and low cost. It is suitable for the rapid and accurate identification of Pediococcus lactis and has promising application prospects in food fermentation, probiotic detection, and microbial quality control.

The present application discloses a lactic acid pediococcus SWU-HX39 with the function of reducing uric acid, and the classification name is lactic acid pediococcus (Pediococcus acidilactici) Pediococcus acidilactici ), which is preserved in the China General Microbiological Culture Collection Center, with the preservation number of CGMCC No.33055, the preservation date of December 13, 2024, and the preservation address of No.3, Xili, Beichen West Road, Chaoyang District, Beijing. The lactic acid pediococcus SWU-HX39 can relieve the kidney damage caused by high uric acid, reduce the synthesis of uric acid, lower the concentration of uric acid in blood, improve the excretion of uric acid in the body, reduce the reabsorption of uric acid in the body, and achieve the effect of reducing uric acid. In addition, SWU-HX39 can reduce the expression of LPS and the expression of inflammatory factors IL-1beta, IL-6 and TNF alpha. That is, it has the functions of anti-inflammation and relieving liver inflammation, and can also increase the content of SCFAs in the body of patients with high uric acid, especially propionic acid, so as to reduce the uric acid level and improve the abnormal uric acid content.

This invention provides a probiotic, a probiotic composition, and their applications, all possessing the functions of calcium ion enrichment and vitamin K synthesis. This invention belongs to the field of microbial technology. The probiotic provided by this invention is *Lactobacillus bulgaricus* subsp. Lactobacillus delbrueckii subsp. bulgaricus NWP-101 or Pyrococcus lactis ( Pediococcus acidilactici NWP-299 has the advantages of efficient calcium enrichment, high vitamin K production and excellent probiotic properties. It can be used to prepare probiotic preparations, functional foods, health foods or dietary supplements to prevent or improve osteoporosis and increase bone density.

The application discloses a fermentation process of peanut meal, a fermentation product of the peanut meal, a compound bacterial preparation and application of the compound bacterial preparation, and belongs to the technical field of fermented peanut meal, and adopts compound bacteria to ferment peanut meal mixture; the compound bacteria are bacillus velezensis, pediococcus acidilactici, bacillus subtilis, lactobacillus plantarum and thermotolerant saccharomyces cerevisiae; the compound bacterial preparation is composed of compound bacterial liquid, and the compound bacterial preparation is applied to feed preparation or water quality improvement; through the disclosed compound bacterial fermentation system, high-efficiency degradation of aflatoxin in peanut meal with high aflatoxin content can be realized, meanwhile, the contents of crude protein, acid-soluble protein and small peptides are simultaneously greatly increased, the process is simplified, the application scenarios are wide, and the limitation of single fermentation function and complex operation of existing strains is broken through.

The application provides a complex lactobacillus for improving insulin resistance and application thereof, and belongs to the technical field of microorganism application. The complex lactobacillus comprises Pediococcus acidilactici NWP-182, Lactobacillus plantarum NWP-242 and Lactobacillus rhamnosus NWP-263. The complex lactobacillus is natural in source, high in safety and good in tolerance, overcomes the side effect problem of traditional drugs and the defect that general probiotics have unclear functions, provides a safe and effective new technical scheme for preventing and / or assisting in treating metabolic diseases such as type 2 diabetes and insulin resistance, and has extremely high social benefits and broad market application prospects.

This invention provides a composition containing lactic acid bacteria and its use in lowering dihydrotestosterone and improving hyperandrogenemia. The composition can lower dihydrotestosterone and improve androgenemia. The lactic acid bacteria comprise *Lactobacillus helveticus* GKS3, *Lactobacillus brevis* GKL9, *Lactobacillus johnsonii* GKJ2, *Pediococcus acidilactici* GKA4, or a combination thereof.

The present application relates to a kind of juice compound ferment formulation with hypoglycemic, hypolipidemic and antioxidant complex function and its application, and the present application belongs to food processing technical field.The method relates to the functional compound ferment by lactobacillus plantarum and pediococcus acidilactici, wherein lactobacillus plantarum FM-LP-BC17 has hypoglycemic capacity and excellent fermentation performance, lactobacillus plantarum FM-LP-9 has high efficient antioxidant function and excellent fermentation performance, and pediococcus acidilactici FM-Pa-JXM94 has hypoglycemic capacity, and the ratio of the number of bacteria in compound ferment formulation FM-LP-BC17, FM-LP-9 and FM-Pa-JXM94 is 3:2~3:2~3.Juice fermented by the compound ferment can significantly improve the antioxidant, hypoglycemic and hypolipidemic capacity of juice, and has wide application prospect.

This invention discloses a strain of *Pediococcus pentosaceus* and its applications, belonging to the field of microbial technology. The strain is *Pediococcus pentosaceus* (…). Pediococcus acidilactici L27, with accession number CCTCC NO: M 20252576, has the following outstanding characteristics: (1) strong cholesterol-lowering ability in vitro; (2) excellent tolerance to the gastrointestinal environment, maintaining a high survival rate in simulated gastric juice and bile salt-containing environments; (3) able to produce broad-spectrum antibacterial substances mainly composed of organic acids, which can inhibit a variety of foodborne pathogens and have stable antibacterial properties; (4) possessing hydrophobic cell surface and co-aggregation ability with pathogens, showing potential for intestinal colonization competition; and (5) having no hemolytic activity and good safety. The L27 strain of this invention can be used to prepare drugs, fermented dairy products, probiotic preparations or feed additives with cholesterol-lowering and / or intestinal flora regulation functions, providing a core strain resource for the development of multifunctional, efficient and stable new probiotic products.

This invention relates to the field of microbial technology, specifically to a strain of *Pediococcus acidilactici* QHBM076, a composition containing the strain, and its uses. The *Pediococcus acidilactici* is *Pediococcus acidilactici* QHBM076, with accession number CCTCC NO: M 20252988, deposited at the China Center for Type Culture Collection. The composition comprises at least one of *Pediococcus acidilactici* and a culture of the strain. The use of the composition in the preparation of compositions for feed fermentation is also discussed. The advantages of this invention are: (1) it can efficiently degrade mycotoxins; (2) it possesses probiotic properties, strong growth performance, and strong resistance to acid, bile salts, and osmotic pressure; (3) it has good hydrophobicity and self-aggregating properties; and (4) it has high safety.

This invention discloses a strain of *Pediococcus lactis* GBW9011 and its preparation as a solid microbial preparation for preventing diarrhea in weaned rabbits, belonging to the field of microbial preparations. This invention provides a strain of *Pediococcus lactis* GBW9011, with the preservation number CGMCC No. 34454. This invention utilizes *Pediococcus lactis* GBW9011 to ferment and enrich inorganic zinc ions, preparing zinc-rich lactic acid bacteria powder. This powder is then mixed with a compound enzyme preparation, fructooligosaccharides, and compound vitamins to prepare a solid microbial preparation. This solid microbial preparation can prevent diarrhea in weaned rabbits, exerting a synergistic effect through "inhibiting pathogens, strengthening the barrier, aiding digestion, and resisting stress," significantly reducing the incidence of diarrhea in weaned rabbits, increasing weight gain and survival rates, improving digestive enzyme activity, and improving intestinal flora structure. This has significant implications for animal husbandry, including rabbits.

The application discloses a peanut meal fermentation process by using composite bacteria and a fermentation product thereof, and belongs to the technical field of peanut meal fermentation. The process comprises the following steps: fermenting peanut meal mixture by using composite bacteria; the composite bacteria are bacillus velezensis, bacillus amyloliquefaciens, pediococcus acidilactici and lactobacillus rhamnosus; the composite bacteria are prepared into composite bacteria liquid before fermentation; the composite bacteria liquid is composed of bacillus velezensis liquid, bacillus amyloliquefaciens liquid, pediococcus acidilactici liquid and lactobacillus rhamnosus liquid. By adopting the co-fermentation system of bacillus and lactic acid bacteria, the functions of enzymolysis, detoxification, pH adjustment and bacteriostasis are synergized, the retention rate of crude protein in the fermentation product is high, the contents of acid-soluble protein and small peptides are greatly increased, the removal effect of aflatoxin is remarkable, the pH is reduced to the acidic range, and the biological safety is improved.

The invention belongs to the technical field of microorganisms, and discloses a pediococcus acidilactici MA8 with blood fat reducing activity and application of the pediococcus acidilactici MA8 in sour soup fermentation, the strain is pediococcus acidilactici MA8 and is preserved in Guangdong Microbial Culture Collection Center on May 19, 2025, and the preservation number is GDMCC No. 66353. The invention further discloses a preparation method of the pediococcus acidilactici MA8. The strain has excellent acid production, acid resistance and cholate resistance, and in-vitro experiments prove that the strain can effectively degrade cholesterol and reduce the triglyceride level and meets the food-grade microorganism safety standard. When a leavening agent prepared from the strain is applied to fermentation of the red sour soup, the fermentation period can be remarkably shortened, the total acid content of the obtained red sour soup product reaches (16.79 + / -0.90) g / kg, and the red sour soup product has excellent in-vitro lipid-lowering activity and is suitable for industrial production of standardized and functionalized red sour soup.

The application belongs to the technical field of feed processing, and specifically provides a storage-resistant palm kernel meal fermented feed, which comprises 75-95 parts of palm kernel meal, 1-5 parts of probiotic preparation and 2-10 parts of composite enzyme preparation by weight; the probiotic preparation comprises Pediococcus acidilactici, Saccharomycetes and Bacillus coagulans; and the composite enzyme preparation comprises cellulase, mannanase, pectinase and neutral protease. The storage-resistant palm kernel meal fermented feed provided by the application prolongs the shelf life of the product by optimizing the formula of the fermentation agent without adding any antibiotics and only using the effect of fermentation, and the fermented palm kernel meal can be stored for three to four months under high-moisture conditions without drying and can be directly fed to animals.

Novel strains of Lactobacillus plantarum GCWB1001 deposited as accession number KCCM12698P, Pediococcus acidilactici GCWB1085 deposited as accession number KCCM12699P, or Lactobacillus rhamnosus GCWB1156 deposited as accession number KCCM12700P are disclosed. The novel strains have the excellent effect of treating or alleviating respiratory diseases. Additionally, provided are a pharmaceutical composition, a health functional food composition, and probiotics, all of which have the effect of treating or alleviating inflammatory diseases or respiratory diseases, containing any one of the novel strains.

The present application relates to the technical field of microorganism, in particular to a strain of Enterococcus hirae QHBMA068, a composition containing the same and use thereof.The Enterococcus hirae is Enterococcus hirae QHBMA068, the preservation number of which is CCTCC NO: M 20252987, and it is preserved in China Center for Type Culture Collection.The composition contains at least one of Pediococcus acidilactici and a culture of the strain.The composition is used for preparing a composition for feed fermentation.The present application has the following advantages: (1) high efficiency in degrading mycotoxins; (2) good probiotic properties, strong growth performance, strong acid tolerance, bile salt tolerance and osmotic pressure tolerance; (3) good hydrophobicity and self-aggregation performance; and (4) high safety.